[1] |
卢国兴. 贫血诊断学[M]. 北京:人民卫生出版社,2015: 177-202.
|
[2] |
Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia [J]. Lancet, 2018, 391(10116): 155-167.
|
[3] |
M. Domenica Cappellini, Irene Motta. New therapeutic targets in transfusion-dependent and -independent thalassemia [J]. Hematology Am Soc Hematol Educ Program, 2017, 2017(1): 278-283.
|
[4] |
姚莉琴,邹团标,刘锦桃,等. 云南省22 287对婚检人群地中海贫血基因型分布状况及干预模式探讨[J]. 中国优生与遗传杂志,2017, 25(11): 31-34.
|
[5] |
Hanprasertpong T, Kor-anantakul O, LeetanapornR, et al. Pregnancy outcomes amongst thalassemia traits [J]. Arch Gynecol Obstet, 2013, 288(5): 1051-1054.
|
[6] |
Traeger-Synodinos J, Harteveld CL. Preconception carrier screening and prenatal diagnosis in thalassemia and hemoglobinopathies: challenges and future perspectives [J]. Expert Rev Mol Diagn, 2017, 17(3):281-291.
|
[7] |
王燕燕,李晓辉,徐西华. 地中海贫血诊治进展与我国现状[J]. 中国实用儿科杂志,2013, 28(6): 473-476.
|
[8] |
Li DZ, Yang YD. Invasive prenatal diagnosis of fetal thalassemia [J]. Best Pract Res Clin Obstet Gynaecol, 2017, 39:41-52.
|
[9] |
Xiong L, Barrett AN, Hua R, et al. Non-invasive prenatal diagnostic testing for β-thalassaemiausing cell-free fetal DNA and next generation sequencing [J]. Prenat Diagn, 2015, 35(3): 258-265.
|
[10] |
Lao TT. Obstetric care for women with thalassemia [J]. Best Pract Res Clin Obstet Gynaecol, 2017, 39: 89-100.
|
[11] |
Naik RP, Lanzkron S. Baby on board: what you need to know about pregnancy in the hemoglobinopathies [J]. Hematology Am Soc Hematol Educ Program, 2012, 2012: 208-214.
|
[12] |
Diamantidis MD, Neokleous N, Agapidou A, et al. Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic [J]. Int J Hematol, 2016, 103(5): 537-544.
|
[13] |
Li H, Gu WR. Mirror syndrome associated with heart failure in a pregnant woman: a case report [J]. Int J ClinExp Med, 2015, 8(9): 16132-16136.
|
[14] |
Songdej D, Babbs C, Higgs DR, et al. An international registry of survivors with Hb Bart's hydrops fetalis syndrome [J]. Blood, 2017, 129(10): 1251-1259.
|
[15] |
涂新枝,王晨虹. 镜像综合征21例临床分析[J/CD]. 中华产科急救电子杂志,2016, 5(1): 36-39.
|
[16] |
Braun T, Brauer M, Fuchs I, et al. Mirror syndrome a systematic review of fetal associated conditions,maternal presentation and perinatal outcome [J]. Fetal DiagnTher, 2010, 27(4): 191-203.
|
[17] |
Moake JL. Thrombotic microangiopathies [J]. N Engl J Med, 2002, 347(8): 589-600.
|
[18] |
Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura [J]. Blood, 2008, 112(1): 11-18.
|
[19] |
Scully M, Hibbard C, Ewenstein B. Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura [J]. Oncoscience, 2017, 4(11-12): 160-161.
|
[20] |
Cines DB, Levine LD. Thrombocytopenia in pregnancy [J]. Blood, 2017, 130(21): 2271-2277.
|
[21] |
Matsumoto M, Fujimura Y, Wada H, et al. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan [J]. Int J Hematol, 2017, 106(1): 3-15.
|
[22] |
Scully M. Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome microangiopathy in pregnancy [J]. Semin Thromb Hemost, 2016, 42(7): 774-779.
|
[23] |
Saha M, McDaniel JK, Zheng XL. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics [J]. J Thromb Haemost, 2017, 15(10): 1889-1900.
|
[24] |
Sadler JE. Pathophysiology of thrombotic thrombocytopenic purpura [J]. Blood, 2017, 130(10): 1181-1188.
|
[25] |
Lam MTC, Dierking E. Intensive Care Unit issues in eclampsia and HELLP syndrome [J]. Int J CritIllnInj Sci, 2017, 7(3): 136-141.
|
[26] |
Haram K, Mortensen JH, Mastrolia SA, et al. Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know? [J]. J Matern Fetal Neonatal Med, 2017, 30(7): 779-788.
|
[27] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015) [J]. 中华妇产科杂志,2015, 50(10): 721-728.
|
[28] |
Mao M, Chen C. Corticosteroid Therapy for Management of Hemolysis,Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome: A Meta-Analysis [J]. Med Sci Monit, 2015, 3(21): 3777-3783.
|